Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo

Hayashi Masahiro; Okamura Ken; Abe Yuko; Hozumi Yutaka; Suzuki Tamio

首页> 外文期刊>The Journal of dermatology >Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo

【24h】

Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo

机译：Janus激酶抑制剂TOFACITINIB不促进小鼠模型的rhodendrol诱导的白癜风模型的重新衰减

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of dermatology》 |2019年第6期|共3页
作者
Hayashi Masahiro; Okamura Ken; Abe Yuko; Hozumi Yutaka; Suzuki Tamio;
展开▼
作者单位

Yamagata Univ Dept Dermatol Sch Med Yamagata Japan;

Yamagata Univ Dept Dermatol Sch Med Yamagata Japan;

Yamagata Univ Dept Dermatol Sch Med Yamagata Japan;

Yamagata Univ Dept Dermatol Sch Med Yamagata Japan;

Yamagata Univ Dept Dermatol Sch Med Yamagata Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo [J] . Hayashi Masahiro, Okamura Ken, Abe Yuko, The Journal of dermatology . 2019,第6期

机译：Janus激酶抑制剂TOFACITINIB不促进小鼠模型的rhodendrol诱导的白癜风模型的重新衰减
2. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure [J] . Liu Lucy Y., Strassner James P., Refat Maggi A., Journal of the American Academy of Dermatology . 2017,第4期

机译：使用Janus激酶抑制剂Tofacitinib的白癜风中的复发可能需要伴随的曝光
3. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS) [J] . Yokoyama Seiji, Perera Pin-Yu, Terawaki Seigo, Journal of Clinical Immunology . 2015,第7期

机译：Janus激酶抑制剂Tofacitinib在自身免疫性淋巴组织增生综合征（ALPS）小鼠模型中显示出强效功效
4. Correlation of a Tyrosine Kinase Inhibitor Distribution with Proteome Response in a Glioma Mouse Model by MALDI Imaging Mass Spectrometry [C] . Sara L. Frappier, Richard M. Caprioli ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：MALDI成像质谱法在胶质瘤小鼠模型中对蛋白质组反应的酪氨酸激酶抑制剂分布的相关性
5. Synthesis of Small Molecule Inhibitors of Janus Kinase 2, Phosphodiesterase IV, GABAA and NMDA receptors: Investigation of Mcmurry, Mannich and Chemoenzymatic Strategies [D] . Gali, Meghanath 2011

机译：Janus激酶2，磷酸二酯酶IV，GABAA和NMDA受体的小分子抑制剂的合成：Mcmurry，Mannich和化学酶策略的研究
6. Repigmentation in vitiligo using the janus kinase inhibitor tofacitinib may require concomitant light exposure [O] . Lucy Y. Liu, James P. Strassner, Maggi A. Refat, -1

机译：使用janus激酶抑制剂tofacitinib替代白癜风可能需要同时进行光照
7. 1251 Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mice model of rhododendrol-induced leukoderma [O] . M. Hayashi, K. Okamura, Y. Abe, 2018

机译：1251 Janus激酶抑制剂TOFACITINIB不促进杜鹃花诱导的白昔粒症的小鼠模型中的重新成像

Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol-induced vitiligo

著录项

相似文献

相关主题

期刊订阅